SLN

Silence Therapeutics Plc · NASDAQ

$19.79USDCS band Caution

↑ $0.01 (0.03%) Today

As of Oct 27, 1:05 PM ET · May be delayed

Sign up free to see this.

Daily prices
Mkt Cap
$1.2B
Volume
4.6M
52W High
$19.87
52W Low
$4.19
PE Ratio
—
Avg Vol
4.2M
As of 10/26/26
Div Yield
—
Beta
1.56
As of 10/26/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about SLN?

Latest news

News ›

Zacks Investment Research

Silence Therapeutics (SLN) Upgraded to Buy: Here's Why

Silence Therapeutics PLC (SLN) received an upgrade to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The company's consensus estimate has increased 5.7% over the past three months, positioning it in the top 20% of Zacks-covered stocks for estimate revisions. The upgrade reflects improving business fundamentals that could drive near-term stock price appreciation.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev